Xueqing Lun

2.1k total citations
26 papers, 1.3k citations indexed

About

Xueqing Lun is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Xueqing Lun has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Genetics and 10 papers in Oncology. Recurrent topics in Xueqing Lun's work include Virus-based gene therapy research (15 papers), Glioma Diagnosis and Treatment (7 papers) and RNA Interference and Gene Delivery (7 papers). Xueqing Lun is often cited by papers focused on Virus-based gene therapy research (15 papers), Glioma Diagnosis and Treatment (7 papers) and RNA Interference and Gene Delivery (7 papers). Xueqing Lun collaborates with scholars based in Canada, United States and China. Xueqing Lun's co-authors include Peter Forsyth, Donna L. Senger, Samuel Weiss, Franz J. Zemp, Stephen M. Robbins, J. Gregory Cairncross, John J. Kelly, Owen D.M. Stechishin, Beichen Sun and Grant McFadden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Neuroscience.

In The Last Decade

Xueqing Lun

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xueqing Lun Canada	19	644	479	431	316	313	26	1.3k
Christopher S. Hackett United States	18	1.1k 1.7×	1.1k 2.3×	375 0.9×	256 0.8×	504 1.6×	25	2.3k
Kurt M. Kroeger United States	28	908 1.4×	569 1.2×	797 1.8×	305 1.0×	753 2.4×	52	2.0k
Huong Muzik Canada	15	839 1.3×	622 1.3×	320 0.7×	143 0.5×	138 0.4×	22	1.4k
Maria C. Speranza United States	12	463 0.7×	460 1.0×	427 1.0×	113 0.4×	200 0.6×	21	982
Ken Sasai Japan	16	1.2k 1.8×	396 0.8×	167 0.4×	242 0.8×	172 0.5×	29	1.5k
Ivo J. Huijbers Netherlands	24	954 1.5×	595 1.2×	205 0.5×	83 0.3×	315 1.0×	43	1.6k
Marianela Candolfi United States	23	738 1.1×	460 1.0×	679 1.6×	232 0.7×	536 1.7×	29	1.5k
Sushrusha Nayak United States	20	1.1k 1.7×	462 1.0×	832 1.9×	107 0.3×	343 1.1×	24	2.0k
Johanna ten Hoeve United States	16	1.1k 1.7×	589 1.2×	227 0.5×	231 0.7×	613 2.0×	26	1.9k
Kathrin M. Bernt United States	23	1.8k 2.8×	453 0.9×	539 1.3×	104 0.3×	139 0.4×	58	2.4k

Countries citing papers authored by Xueqing Lun

Since Specialization

Citations

This map shows the geographic impact of Xueqing Lun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueqing Lun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueqing Lun more than expected).

Fields of papers citing papers by Xueqing Lun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueqing Lun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueqing Lun. The network helps show where Xueqing Lun may publish in the future.

Co-authorship network of co-authors of Xueqing Lun

This figure shows the co-authorship network connecting the top 25 collaborators of Xueqing Lun. A scholar is included among the top collaborators of Xueqing Lun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueqing Lun. Xueqing Lun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nechanitzky, Robert, Xueqing Lun, Jun Li, et al.. (2024). EXTH-15. AN EGFRVIII RNA-LNP VACCINE PROTOTYPE ACHIEVES TUMOUR CLEARANCE IN A GBM MOUSE MODEL. Neuro-Oncology. 26(Supplement_8). viii239–viii239.

Thakur, Satbir, Yibing Ruan, Chunfen Zhang, et al.. (2020). Human SNF5 arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells. Cancer Gene Therapy. 28(7-8). 739–744. 6 indexed citations

Jiang, Bin, Xueqing Lun, Xiaoguang Hao, et al.. (2017). Temozolomide resistant human brain tumor stem cells are susceptible to recombinant vesicular stomatitis virus and double-deleted Vaccinia virus in vitro. Biomedicine & Pharmacotherapy. 95. 1201–1208. 11 indexed citations

Beug, Shawn T., Martine St-Jean, Aditya Mohan, et al.. (2017). Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma. Nature Communications. 8(1). 106 indexed citations

Lun, Xueqing, J. Connor Wells, Natalie Grinshtein, et al.. (2016). Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma. Clinical Cancer Research. 22(15). 3860–3875. 169 indexed citations

Grinshtein, Natalie, Richard Marcellus, David Uehling, et al.. (2016). Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells. Oncotarget. 7(37). 59360–59376. 30 indexed citations

Pisklakova, Alexandra, Brienne McKenzie, Franz J. Zemp, et al.. (2016). M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma. Neuro-Oncology. 18(8). 1088–1098. 41 indexed citations

Luchman, H. Artee, Owen D.M. Stechishin, Stephanie A. Nguyen, et al.. (2014). Dual mTORC1/2 Blockade Inhibits Glioblastoma Brain Tumor Initiating Cells In Vitro and In Vivo and Synergizes with Temozolomide to Increase Orthotopic Xenograft Survival. Clinical Cancer Research. 20(22). 5756–5767. 44 indexed citations

Zemp, Franz J., Brienne McKenzie, Xueqing Lun, et al.. (2014). Cellular Factors Promoting Resistance to Effective Treatment of Glioma with Oncolytic Myxoma Virus. Cancer Research. 74(24). 7260–7273. 28 indexed citations

10.

Nguyen, Stephanie A., Owen D.M. Stechishin, H. Artee Luchman, et al.. (2014). Novel MSH6 Mutations in Treatment-Naïve Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of MGMT Promoter Methylation. Clinical Cancer Research. 20(18). 4894–4903. 50 indexed citations

11.

Weng, Mingzhe, Wei Gong, Mingzhe Ma, et al.. (2014). Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo. Molecular Cancer. 13(1). 82–82. 22 indexed citations

12.

Singh, Anjali, Xueqing Lun, Aarthi Jayanthan, et al.. (2013). Profiling pathway‐specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR‐ ErbB2 signaling with lapatinib. Molecular Oncology. 7(3). 497–512. 27 indexed citations

13.

Ogbomo, Henry, Franz J. Zemp, Xueqing Lun, et al.. (2013). Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo. PLoS ONE. 8(6). e66825–e66825. 49 indexed citations

14.

Sarkar, Susobhan, Axinia Döring, Franz J. Zemp, et al.. (2013). Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells. Nature Neuroscience. 17(1). 46–55. 165 indexed citations

15.

Zemp, Franz J., Brienne McKenzie, Xueqing Lun, et al.. (2013). Resistance to Oncolytic Myxoma Virus Therapy in Nf1−/−/Trp53−/− Syngeneic Mouse Glioma Models Is Independent of Anti-Viral Type-I Interferon. PLoS ONE. 8(6). e65801–e65801. 15 indexed citations

16.

Zemp, Franz J., et al.. (2010). Oncolytic viruses as experimental treatments for malignant gliomas: Using a scourge to treat a devil. Cytokine & Growth Factor Reviews. 21(2-3). 103–117. 47 indexed citations

17.

Lun, Xueqing, Jennifer A. Chan, Hongyuan Zhou, et al.. (2010). Efficacy and Safety/Toxicity Study of Recombinant Vaccinia Virus JX-594 in Two Immunocompetent Animal Models of Glioma. Molecular Therapy. 18(11). 1927–1936. 77 indexed citations

18.

Błasiak, Barbara, Bogusław Tomanek, Abedelnasser Abulrob, et al.. (2010). Detection of T2 changes in an early mouse brain tumor. Magnetic Resonance Imaging. 28(6). 784–789. 18 indexed citations

19.

Kelly, John J., Owen D.M. Stechishin, Andrew Chojnacki, et al.. (2009). Proliferation of Human Glioblastoma Stem Cells Occurs Independently of Exogenous Mitogens. Stem Cells. 27(8). 1722–1733. 148 indexed citations

20.

Wang, Limei, Jennifer J. Rahn, Xueqing Lun, et al.. (2008). Gamma-Secretase Represents a Therapeutic Target for the Treatment of Invasive Glioma Mediated by the p75 Neurotrophin Receptor. PLoS Biology. 6(11). e289–e289. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact